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Summary
During animal cell division, an actin-based ring cleaves the
cell into two. Problems with this process can cause chro-
mosome missegregation and defects in cytoplasmic inher-
itance and the partitioning of organelles, which in turn are
associated with human diseases [1–3]. Although much is
known about how chromosome segregation is coupled to
cell division, the way organelles coordinate their inheri-
tance during partitioning to daughter cells is less well
understood. Here, using a high-content live-imaging small
interfering RNA screen, we identify Myosin-XIX (Myo19) as
a novel regulator of cell division. Previously, this actin-
based motor was shown to control the interphase move-
ment of mitochondria [4]. Our analysis shows that Myo19
is indeed localized to mitochondria and that its silencing
leads to defects in the distribution of mitochondria within
cells and in mitochondrial partitioning at division. Further-
more, many Myo19 RNAi cells undergo stochastic division
failure—a phenotype that can be mimicked using a treat-
ment that blocks mitochondrial fission and rescued by
decreasing mitochondrial fusion, implying that mitochon-
dria can physically interfere with cytokinesis. Strikingly,
using live imaging we also observe the inappropriate move-
ment of mitochondria to the poles of spindles in cells
depleted for Myo19 as they enter anaphase. Since this phe-
nocopies the results of an acute loss of actin filaments in
anaphase, these data support a model whereby the Myo19
actin-based motor helps to control mitochondrial move-
ment to ensure their faithful segregation during division.
The presence of DNA within mitochondria makes their7Co-first author
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creativecommons.org/licenses/by/3.0/).inheritance an especially important aspect of symmetrical
cell division.
Results and Discussion
To ensure faithful organelle inheritance, the segregation of
each cellular component must be tightly coupled to the act
of cell division. For chromosomes, this coupling relies on the
exchange of signals between the elongating anaphase spindle
and the overlying cell cortex, which helps to position the site at
which the actomyosin-based ring is formed that cuts the cell
into two [5]. Although the mechanisms are less well worked
out, organelles may also rely on crosstalk between the micro-
tubule-based spindle and the actin cortex for their partitioning
[6–8]. To identify new actin-based regulators of cell division,
we screened a human ‘‘actinome’’ small interfering RNA
(siRNA) library [9] for siRNAs that induce division errors, tar-
geting genes associated with the actin cytoskeleton, genes
with predicted actin-binding domains, myosin motors, Rho
family GTPases, GTPase activating proteins (GAPs), and gua-
nine nucleotide exchange factors for siRNAs that induce divi-
sion errors. While previous screens had used fixed endpoint
assays to identify cytoskeletal regulators whose silencing led
to cytokinesis failure (e.g., [10]), here we aimed to combine
fixed data with live imaging to identify siRNAs that caused
more subtle division errors.
Briefly, for the live-imaging analysis, a library targeting the
human actinome, four siRNAs per gene, was mixed with a
transfection reagent and arrayed in spots onto glass chamber
slides [11]. HeLa-13 cells expressing LifeAct-EGFP to label
filamentous actin and histone-2B-mCherry to label DNA [12]
were then plated onto these arrays in triplicate experiments.
Approximately 2 days after solid-phase reverse transfection,
these marked islands of siRNA-treated cells were then filmed,
using automated microscopy, to take a frame every 33 min
over a 20 hr period. All images are freely available on our
curated RNAi website FLIGHT.
We focused our manual screen analysis on hits (n = 67) that
exhibited a multinucleated RNAi phenotype in the fixed screen
carried out using the same library [9]. Movies were visually in-
spected to identify siRNAs inducing cell division defects. For
the 18/67 hits with the most reproducible oligo-specific RNAi
phenotypes, division outcome was scored for 100 cells in
each film andwas comparedwith the outcomes from siControl
spots on the same slide. Using this approach, nine candidate
genes were identified that exhibited a cell division defect
with more than one independent siRNA (Figure 1A; for details
of these siRNAs and their individual phenotypes, see Table
S1 and see Figure S1A, available online, for a graphical depic-
tion of the workflow).
The strongest hits corresponded to genes known to be
crucial for faithful cell division, including Anillin [13], Citron ki-
nase [14], and Ect2 [15]. The centralspindlin subunit Rac
GTPase activating protein 1 (RACGAP1, MgcRacGAP) [16]
was also identified as a moderately strong hit, together with
twomembers of the beta-spectrin family [17], which bind actin
and aremajor constituents of the cell cortex, and an unconven-
tional myosin, Myosin-XIX (Myo19) [4]. Finally, BCR, which
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Figure 1. A Live-Image Screen Identifies a Role for Myo19 in Faithful Cell Division
(A) Division failure resulting in a multinucleated HeLa cell during live imaging from day 2 to day 3 postsilencing of various genes is shown relative to the
negative siControl. The screen was performed in triplicate with four independent siRNAs per gene. The pooled mean of each gene is shown; bars indicate
SD. See Figure S1A for a summary of the workflow and Table S1 for the individual siRNA phenotypes.
(B) Bright-fieldmicrographs of cells live imaged every 3min for 48 hr after silencing with the indicated siRNAs. Cell of interest is in middle of field; timestamp
is in minutes, with zero set to the beginning of anaphase. Scale bars, 10 mm.
(C) Quantification of two experiments similar to that shown in (B) indicating mean percentage (at least 100 cells were counted per experiment) of cells that
failed cell division early (soon after furrow formation) or late (later on in cytokinesis).
(D) Representative micrographs of HeLa cells silenced with the indicated siRNAs and fixed 65 hr posttransfection. DAPI staining (DNA) is blue, phalloidin
(F-actin) is red, and cytochrome c is gray. Scale bars, 50 mm.
(E) Quantification of three experiments similar to (D) (at least 100 cells were counted per experiment; bars are SD).
(F) Micrographs of theHeLa BACmuMyo19 cell line, showing that theMyo19 division phenotype is rescued by amurineBAC copy of the gene. The grayscale
images show individual channels as indicated; the color composite image shows DAPI staining (DNA; blue), cytochrome c (mitochondria; red), and GFP
(muMyo19-GFP; green). Scale bar, 30 mm.
(G) Gene silencing of Myo19 compared with control in strongly GFP-positive HeLa BAC muMyo19 cells versus nontransgenic HeLa cells, showing that the
muMyo19 can rescue the multinucleated cell phenotype caused by Myo19 knockdown alone. Experiment was performed three times with triplicate wells;
the mean and SD of percent multinucleated cells is shown.
(H) Representative images from experiment performed in (G); same color channels as for (F). Scale bar, 10 mm. See Figures S1B and S1C for quantitation of
the phenotype in an independent cell type and Figure S1D for quantitation of the siRNA silencing in HeLa cells by quantitative PCR.
See also Figure S1 and Table S1.
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2599contains a C-terminal GAP domain specific for Rac [18],
and TPM4 (tropomyosin 4 [19]) were recovered as relatively
weak hits.
Given its potential novelty, we chose to focus our further
analysis on the role of the unconventional myosin Myo19.Briefly, Myo19 is a myosin found in most animals [20] that
appears to have been lost from lineages leading to insects
and roundworms [21]. The 970 amino acid protein consists
of amotor domain that has features distinguishing it fromother
myosin classes [22–24], a lever arm region containing three
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2600light-chain-binding IQ-motifs, and a tail domain. Interestingly,
the tail domain of Myo19, which is unique in the myosin family,
was recently shown to target the protein to mitochondria [4].
This Myo19-specific mitochondria outer membrane associa-
tion (MyMOMA) domain consists of approximately 150 amino
acids (140 in mouse), bearing little easily identifiable sequence
or structural homology to other known domains. Previous
biochemical studies of purified Myo19 confirmed that the
protein is a plus-end-directed [25], actin-activated ATPase
capable of translocating actin filaments in vitro [22]. These
studies also suggested that Myo19 may spend a large fraction
of its chemomechanical cycle in an actin-bound state—aprop-
erty common to transport motors such as Myo5 [26]. More-
over, the ectopic expression of full-lengthMyo19was reported
to increase the motility of mitochondria in interphase and to
alter mitochondrial network organization in an actin-depen-
dent fashion [4]. Given this, it was important to first confirm a
role for Myo19 in division, before going on to test whether
Myo19 might influence the outcome of cell division through
its interaction with mitochondria.
Myo19 Knockdown Leads to Cytokinesis Failure
Using a Myo19 siRNA (Myo19-03), we were able to confirm the
increased rate of division failure following Myo19 silencing
using live imaging (Figure 1B) and to show that in the majority
of cases (37/41), division first failed soon after furrow forma-
tion, while only a small number of cells failed later (Figure 1C).
To validate this Myo19 RNAi phenotype, we silenced the gene
using nonoverlapping siRNAs. After fixation and staining, we
observed a significant increase in the percentage of Myo19
RNAi cells withmore than one nucleus comparedwith the non-
targeting siControl (Figure 1D). Specifically, after 2 days of
treatment withMyo19-02 siRNA, 14% of cells weremultinucle-
ated, whereas Myo19-03 siRNA caused 30% of the cells to
contain multiple nuclei, compared to 2% of siControl-treated
cells (Figure 1E). A similar phenotype was obtained using
two additional siRNA sets targeting the same gene (data not
shown).
To further validate the specificity of the Myo19 depletion
phenotype, we performed a rescue experiment in a HeLa cell
line stably expressing an N-terminally tagged GFP-bacterial
artificial chromosome (BAC) version of murine Myo19, whose
species-specific nucleotide sequence differences would
make it resistant to knockdown by human Myo19 siRNA. In
these cells, the entire visible pool of GFP-Myo19 was localized
to mitochondria, as confirmed by colabeling with MitoTracker
(data not shown) and by fixing and staining cells with an anti-
body against cytochrome c (Figure 1F). Moreover, in cells
with robust mitochondrial GFP-Myo19 expression (Figure 1G,
with representative images in Figure 1H), we observed a statis-
tically significant reduction in the percentage of multinucle-
ated cells following treatment with Myo19-03 siRNA, implying
a direct or indirect role for thismitochondrially localized pool of
Myo19 in cell division.
As additional validation, we observed a significant increase
in the percentage of multinucleation in a different cell type,
namely, murine cells expressing a stable, lentiviral-induced
Myo19 small hairpin RNA (63% of silenced cells, compared
with 34% in the control; Figure S1B), in which the Myo19
knockdown (ofw80%) could be verified by western blot anal-
ysis using an antibody generated against the mouse protein
(Figure S1C). We also used quantitative PCR to validate the
knockdown following treatment with Myo19-02 and Myo-19-
03 siRNAs in HeLa cells, revealing an 88% reduction withMyo19-02 and a 73% reduction with Myo19-03 oligo relative
to the siControl reagent (Figure S1D). From this point on, we
used Myo19-03 as the representative siRNA for our experi-
ments, as it had the most penetrant phenotype.
Defects in Mitochondrial Organization Can Interfere with
Cell Division
Given that Myo19 is localized to mitochondria, where it has
been implicated in mitochondrial movement [4], it was impor-
tant to test whether defects in the distribution or activity of
mitochondria might be responsible for the observed Myo19
siRNA-induced disruption in cell division. Mitochondria are
known to go through phases of fission and fusion during pas-
sage through the cell division cycle, which are thought to affect
their activity and segregation [27, 28]. More specifically, mito-
chondrial fusion is thought to be accelerated at the G1-S tran-
sition, whereas fission is induced during mitosis [28]. Although
we were unable to identify defects in cell division following
drug-induced inhibition of oxidative phosphorylation (data
not shown), we could phenocopy the multinucleation pheno-
type observed in Myo19 RNAi cells by treating HeLa cells
with mitochondrial division inhibitor 1 (Mdivi), a drug that
shifts the balance toward mitochondrial fusion through the in-
hibition of the fission machinery protein DRP1 [29] (Figure 2A,
representative images in Figure 2B). This result implies that di-
vision failure could ultimately result from the simple obstruc-
tion of the actomyosin ring during cytokinesis by misplaced
or excessively fusedmitochondria inMyo19 RNAi cells. In sup-
port of this idea, both theMdivi1 and theMyo19 depletion phe-
notypes were rescued in cells treated with siRNAs targeting
mitofusin-2 (Mfn2), whose depletion shifts the balance toward
mitochondrial fission [30] (Figures 2C and 2E, with a represen-
tative image in Figures 2D and 2F; see Figure S2A for evidence
of Mfn2 protein reduction). A similar mitochondrial fragmenta-
tion was seen in Mfn2 Myo19 RNAi cells (data not shown). To
determine the longer-term consequences of siMyo19-induced
mitochondrial asymmetry, we followed dividing cell progeny to
see how they coped with a subsequent cell cycle. HeLa cells
stably expressing mitochondria-targeted yellow fluorescent
protein (YFP) were treated with Myo19 siRNA or siControl
and live imaged after 24 hr. As quantified in Figure S2B,
Myo19 cells that failed division in the first round could produce
daughter cells that succeeded in the second, and vice versa.
Therefore, division failure appeared to be stochastic as ex-
pected if it was due to physical obstruction. To examine
whether Myo19 is required for actomyosin ring formation
or closure, we examined mitotic cells after depletion with
siMyo19 or siControl siRNA and could see no obviousmorpho-
logical differences in the contractile ring, as assessed by stain-
ing with an antibody specific for Anillin (Figure S2C). Moreover,
using live imaging, we compared the time it took for cells to
travel from the onset of anaphase to the onset of cytokinesis
and observed no significant difference between control and
Myo19 RNAi cells, whether or not the cell ultimately failed divi-
sion (Figures S2D and S2E). To determine whether the cell di-
vision failure following Myo19 depletion might be due to
improperly segregated chromosomes [31], we live imaged
HeLa cells expressing histone-2B-mCherry after knockdown
with siMyo19. Although we did observe lagging chromosomes
in some control and Myo19 RNAi cells, there was no correla-
tion between the presence of DNA bridges and division failure
(Figure S2F). However, cells with more severe mitochondrial
segregation defects tended to fail division at a higher rate (Fig-
ure S2F). Taken together with themitochondrial fusion findings
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Figure 2. Inappropriate Mitochondrial Fusion
Adversely Affects Cell Division, and Enhanced
Fission Can Rescue the Myo19 Phenotype
(A and B) Quantification of multinucleation in
HeLa cells treated with 10 mM Mdivi (100 cells
were counted; mean of five experiments for 12
or 24 hr), with (B) showing representative cells
at 24 hr posttreatment versus the control DMSO
treatment, immunostained for cytochrome c.
(C and D) Quantitation of multinucleation in HeLa
cells cosilenced with Myo19 and Mfn2 siRNAs
versus the siControl RNA (mean of six experi-
ments, keeping total amount of siRNA constant
with siControl when necessary; 65 hr siRNA treat-
ment time), with (D) showing the fragmented
mitochondria caused by Mfn2 silencing in the
experiment, stained as for (B). A similar fragmen-
tation was seen in Mfn2 Myo19 RNAi cells (data
not shown).
(E and F) Quantitation of multinucleation in HeLa
cells treated with 10 mM Mdivi with either Mfn2
or siControl silencing (mean of three experi-
ments), with (F) showing representative cells,
stained as for (B). Bars are SD in all graphs. Scale
bars, 10 mm. Figure S2A shows a western blot
showing reduced Mfn2 protein expression in the
siMfn2-treated cells; Figures S2B–S2F illustrate
the consequences of mitochondrial asymmetry
for the subsequent cell cycle, showing that acto-
myosin ring structure and closure rates are not
significantly affected by Myo19 depletion and
that DNA bridges are not correlated with failure.
Myo19 Aids Mitochondrial Segregation
2601mentioned above, these results argue that Myo19 is not
an integral part of the cell division machinery or of the actomy-
osin ring.
Myo19 Ensures the Even Distribution and Segregation of
Mitochondria
During the course of these experiments, we noted an addi-
tional phenotype specific to Myo19 RNAi cells: mitochondria
appeared asymmetrically localized in mitotic siMyo19 cells.
Strikingly, while we observed relatively subtle changes in the
structure and organization of mitochondria in interphase (Fig-
ure 3A, left panels), mitochondria appeared clumped and
asymmetrically distributed in both metaphase and anaphase
Myo19 RNAi cells (Figure 3A, montages; quantified in Fig-
ure 3B). As a result, pairs of daughter cells frequently inherited
different proportions of the total mass of mitochondria (Fig-
ure S3A; this effect is quantified for anaphase in Figure S3B
and quantified for telophase in FigureS3C; see also Movies
S1, S2 and S3 for representative examples of an siControl
cell, a Myo19 cell that succeeded in division, and a Myo19
cell that failed, respectively). This phenotype was statisti-
cally significant in experiments using a number of different
Myo19-specific siRNAs (data not shown), was rescued by
the expression of the RNAi-resistant BAC mouse GFP-fusion
protein (Figure S3B, right side).
To determine whether the asymmetric segregation ob-
served might be a simple consequence of defects in mito-
chondrial fission, we cosilenced Myo19 and Mfn2. While
Mfn2 siRNA rescued the multinucleation phenotype seen in
the Myo19 knockdown (Figure 2C), this increase in fission
had no impact on the Myo19-RNAi-induced asymmetry in
mitochondrial inheritance (Figure S3C, right side, with repre-
sentative images as insets). This is important for two reasons.First, it strongly suggests that Myo19 does not exert its effects
on mitochondrial segregation simply by altering the mitochon-
drial fusion status. Second, it enabled us to separate the
effects of Myo19 on cell division, which appear to be due to
a stochastic process in which misplaced mitochondria phys-
ical obstruct the process, from the robust defects in the sym-
metry of mitochondria at division. These distinct functions
could be observed in movies of different dividing Myo19
RNAi HeLa cells stained with MitoTracker Green. As shown
in Figure S3D, mitochondrial positioning was still visibly per-
turbed regardless whether division succeeds (middle row
shows a representative cell) or fails (bottom row). Similar re-
sults were observed when live imaging was performed with a
mitochondria-targeted YFP tag (HeLa-mito-YFP) instead of
MitoTracker (data not shown).
To determine whether Myo19 functions in mitosis to aid the
proper distribution and segregation of mitochondria, we syn-
chronized siMyo19 or siControl HeLa cells transiently express-
ing a-tubulin mCherry in prometaphase with the Eg5-inhibitor
S-trityl-L-cysteine (STLC) [32] for 14 hr and then used
MitoTracker Green to visualize mitochondria in the 30 min
required for cells to exit mitosis following drug washout (Fig-
ure 4A; n = 15 for control and n = 15 for Myo19 RNAi). While
control cells manifested occasional mild mitochondrial asym-
metries at metaphase (e.g., second row for Figure 4A), they
were able to restore symmetry during anaphase. In contrast,
while the distribution of mitochondria appeared similar in the
majority of control and siMyo19 cells arrested in prometa-
phase, following release from the arrest many Myo19 RNAi
cells entering metaphase with a relatively normal mitochon-
drial distribution exhibited profound defects in mitochondrial
segregation. These first arose as mitochondria moved to
cell poles just prior to the onset of anaphase chromosomal
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Figure 3. Myo19 Depletion Causes Mitochondria
to Appear Clumped and to Be Asymmetrically
Distributed in Both Metaphase and Anaphase
(A) Time-lapse imaging (every 3 min at 2 mm sec-
tions) of HeLa cells stably expressing histone-2B-
mCherry, treated with siCON (top set of cells) or
siMyo19 (last two sets of cells) and labeled
with MitoTracker Green 48 hr posttransfection.
Images are maximum projections. Timestamps
in minutes are indicated, with zero set during
onset of early anaphase. Scale bars, 10 mm.
(B) Quantitation of mitochondrial asymmetry in
the same experiment at telophase in cells that
succeed in division (center of graph) or at the
time point prior to failure (right-hand side of
graph). A number greater than 1 indicates relative
asymmetry (see the Supplemental Experimental
Procedures for details).
See also Figure S3 for controls to show that the
asymmetry in mitochondrial localization is inde-
pendent of the state of fusion and can be rescued
by the expression of murine Myo19 and Movies
S1, S2, and S3.
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Figure 4. Myo19 Function Is Required during Mitosis
Mitochondrial asymmetries arising during metaphase are corrected in control cells, but lead to the asymmetric segregation of mitochondria at division in
Myo19-depleted cells. The disruption of filamentous actin leads to similar defects in mitochondrial movement at the onset of anaphase.
(A) HeLa cells transiently expressing an mCherry-tagged a-tubulin protein (red) were synchronized in prometaphase with STLC, stained with MitoTracker
Green, and followed after drug washout using high-resolution spinning disk confocal microscopy. Timestamps are in minutes. Row 1: a control cell with
relatively symmetric mitochondrial distribution that stays symmetric through to cytokinesis. Row 2: symmetry is restored in a control cell with an initially
asymmetric distribution of mitochondria prior to division. Rows 3 and 4: mitochondria tend to be relatively evenly distributed in prometaphase Myo19
RNAi cells but move rapidly to spindle poles just prior to the onset of anaphase, leading to a strikingly asymmetric segregation in some cases. Scale
bars, 16 mm.
(B) Mitochondrial movement in HeLa cells released from STLC treatment and live imaged with MitoTracker Green after treatment with the F-actin inhibitor
latrunculin B or DMSO as a control; the label isMitoTracker Green in the grayscale images, before (left column, time zero) or after (middle column time series)
addition of the indicated agent, every 2min from4min postdrug treatment. The color images (right) showwells fixed at the end of the experiment (after 1.5 hr)
and stained with DAPI for DNA (blue) and phalloidin for F-actin (red), to show that the latrunculin B completely dismantled F-actin in the treated cells.
Scale bars, 10 mm.
(C) Quantification of mitochondrial presence at the poles of anaphase HeLa cells in the experiment depicted in (B), compared with presence in the middle of
the cell, expressed as a ratio. Movies were analyzed in ‘‘total sum’’ mode to capture pixels on all planes. See the Supplemental Experimental Procedures for
quantification details. A number greater than 1 indicates polar enrichment.
See also Figure S4 for quantification of mitochondrial presence at the poles of anaphase HeLa cells in cells live imaged after treatment with siMyo19 or
siControl and subsequent STLC treatment and release, which show a similar latrunculin B phenocopy effect.
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2603movements (Figure 4A, bottom row) and led to defective mito-
chondrial segregation at division (Figure 4A, third row). In addi-
tion, it was noted that Myo19 cells tended to take longer on
average to completemitosis (data not shown). These data pro-
vide evidence that Myo19 functions to regulate mitochondrial
movement and segregation as cells exit mitosis.The correct partitioning of mitochondria into daughter cells
during cell division requires precise orchestration, since de-
fects in this process are likely to have serious consequences
for daughter cells. Aside from their best-known role as pro-
ducers of ATP, mitochondria regulate lipid and amino
acid metabolism, redox regulation, calcium buffering, the
Current Biology Vol 24 No 21
2604production of heme, and apoptosis [33]. Given the funda-
mental and diverse nature of mitochondrial housekeeping
functions, it is no surprise that their disruption is associated
with numerous human diseases [3] and that checkpoints
have been found in yeast that prevent division if problems in
mitochondrial partitioning have occurred [34].
Eukaryotic cells ensure the fair partitioning of mitochondria
using a variety of strategies. For example, in budding yeast,
actin cables are employed to transport mitochondria from
the mother cell to the bud cell [34], whereas in fission yeast,
microtubules move the organelles to opposite poles [35]. The
mechanisms in mammalian cells, however, remain poorly un-
derstood. RAL-induced fission of mitochondria in mitosis
has very recently been proposed to contribute to their parti-
tioning at cell division [36]. Although a recent paper [37] re-
ported thatmitochondriawere recruited to the cleavage furrow
during cytokinesis in HeLa and other cell types, a process its
authors concluded was dependent on microtubules but not
actin, we never observed this in our experiments (see, for
example, Figures 3 and 4A; Figures S3A and S3D; Movie S1).
Given that Myo19 is an actin-binding protein [4], we wanted
to test whether actin is required for the movement of mito-
chondria during early cell division. To this end, we synchro-
nized HeLa cells transiently expressing a-tubulin mCherry in
prometaphase with STLC for 14 hr and then stained with
MitoTracker Green for the last 30 min. After drug washout,
we imaged cells to inspect the behavior of mitochondria
before and then 4 min after the addition of latrunculin B to
disrupt F-actin assembly, or DMSO as a control (representa-
tive images in Figure 4B, with the quantification in Figure 4C).
The disassembly of actin was found to trigger the rapid move-
ment of mitochondria to the two opposing spindle poles of
anaphase cells. Strikingly, this mirrored the premature move-
ment of mitochondria to the spindle poles in Myo19 RNAi cells
passing throughmitosis (Figure 3A) and following the recovery
from a prometaphase arrest (Figure 4A). This finding supports
the idea that actin helps to control the movement of mitochon-
dria during mitosis, but suggests that the actin cytoskeleton
may constrain rather than promote mitochondrial movement
in anaphase, which may be driven by microtubules [37].
Our data therefore support a mechanism whereby the
mitochondrially associated myosin motor Myo19 functions
together with F-actin in ensuring the regulated segregation
of mitochondria during anaphase. This facilitates the equal in-
heritance of these organelles uponmitotic exit. It may also help
to keep mitochondria out of the way of the cleavage plane to
allow easy division of the cell body.
How might Myo19 move and position the mitochondria? In
many other systems, general high-speed and longer-range
transport of organelles on microtubules is refined by local
anchorage to the actin cytoskeleton. For example, in the verte-
brate axon, inhibition studies in vivo showed that mitochon-
drial transport can occur via either microtubules or actin
microfilaments, but both are required for normal speed and
net transport properties [38]. In this system, actin provides
fine-tuning in response to signaling events; for example, nerve
growth factor can induce the accumulation of the organelles
in particular parts of the axon by recruiting mitochondria
from the general microtubule-trafficked pool via filamentous
actin tethers [39]. Similarly, melanosomes undergo kinesin-
mediated radial transport from the center of the cell to its
periphery. Once at the periphery, these organelles switch to
Myo5-mediated transport and localization on actin filaments
[40]. Such ‘‘track-switching’’ also occurs in the Myo5-mediated endoplasmic reticulum transport into dendrites un-
derlying neuronal synaptic plasticity [41].
Our analysis supports a model whereby mitochondria
move to the poles of the microtubule-based spindle at
anaphase in a way that is independent of actin filaments, in
line with the large body of literature showing that mitochon-
dria are carried along microtubules in animal cells [42]. In
this context, Myo19, through its association with mitochon-
dria, may function to tether mitochondria to actin filaments
during metaphase and anaphase, helping to regulate or limit
their association with and poleward movement along micro-
tubules, which provides the driving force for their segregation
[27, 37]. This function would be similar to the role proposed
for many other unconventional myosins as tethers [43].
Further experiments will be required to understand exactly
how Myo19 regulates mitochondrial movement, and to ascer-
tain whether its activity is coupled to mitotic progression—for
example, to determine whether there is regulated disengage-
ment of mitochondria from actin at anaphase. Taken together,
however, our analysis shows that interactions between Myo19
and the actin cytoskeleton likely help to control the intracel-
lular distribution of mitochondria and to ensure their precise
and timely symmetrical segregation to spindle poles during
animal cell division. Because mitochondria are unique among
organelles in carrying their own genome, their missegregation,
in commonwith errors in DNA segregation, would be expected
to have profound effects on the future growth and viability of
daughter cells [44].
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